Share-Based Compensation (Details) (USD $)	12 Months Ended									1 Months Ended	12 Months Ended					1 Months Ended	12 Months Ended				1 Months Ended	12 Months Ended					12 Months Ended
	Feb. 02, 2013 plan	Jan. 28, 2012	Jan. 29, 2011	Feb. 02, 2013 Equity Incentive Plan 2004	Jan. 28, 2012 Equity Incentive Plan 2004	Feb. 02, 2013 2006 Non-Employee Directors Stock Grant and Stock Option Plan	Jan. 28, 2012 2006 Non-Employee Directors Stock Grant and Stock Option Plan	May 09, 2006 2006 Non-Employee Directors Stock Grant and Stock Option Plan	Jul. 30, 1996 2006 Non-Employee Directors Stock Grant and Stock Option Plan	Oct. 31, 2008 Stock option	Feb. 02, 2013 Stock option	Jan. 28, 2012 Stock option	Jan. 29, 2011 Stock option	Feb. 02, 2013 Stock option Selling, general and administrative expenses	Feb. 02, 2013 Stock option Equity Incentive Plan 2004	May 31, 2008 Nonvested stock awards or units	Feb. 02, 2013 Nonvested stock awards or units	Jan. 28, 2012 Nonvested stock awards or units	Jan. 29, 2011 Nonvested stock awards or units	Feb. 02, 2013 Nonvested stock awards or units Selling, general and administrative expenses	Jan. 28, 2012 Nonvested stock awards or units Maurice Marciano	Jan. 28, 2012 Nonvested stock awards or units Maurice Marciano	Feb. 02, 2013 Employee Stock Purchase Plan	Jan. 28, 2012 Employee Stock Purchase Plan	Jan. 29, 2011 Employee Stock Purchase Plan	Jan. 23, 2002 Employee Stock Purchase Plan	Feb. 02, 2013 Equity Incentive Plan 2004 Stock option
Disclosure of share-based compensation information under stock plans
Number of share-based compensation plans	4
Authorized number of shares				20,000,000		2,000,000		1,000,000	1,000,000																	4,000,000
Shares available for grant under the plan				12,835,693	13,429,837	899,931	930,338
Term of award															10 years
Portion of vested and fully exercisable shares granted on each anniversary from the date of the grant																											25.00%
Initial vesting period of the first of three most recent annual grants (in months)															9 months
Initial vesting period of the second of three most recent annual grants (in months)															9 months
Initial vesting period of the last of three most recent annual grants (in months)															10 months
Number of annual vesting periods following the initial vesting period (in years)															3 years
The purchase price expressed as a percentage of the Company's common stock at the beginning or end of the quarterly stock purchase period																							85.00%
Term of consulting agreement																					2 years
Original grant date fair value of the modified equity awards																						$ 4,700,000
Modified grant date fair value																						5,000,000
Nonvested stock awards or units granted (in shares)																167,000	652,240
Vesting period										4 years						5 years
Share-based compensation expense	16,285,000	28,100,000	29,312,000								4,633,000	7,123,000	7,755,000	4,633,000			11,337,000	20,584,000	21,199,000	11,337,000		2,500,000	315,000	393,000	358,000
Number of Shares
Options outstanding at the beginning of the period (in shares)	2,017,285
Granted (in shares)	421,800									563,400
Exercised (in shares)	(314,294)
Forfeited (in shares)	(310,325)
Expired (in shares)	0
Options outstanding at the end of the period (in shares)	1,814,466	2,017,285
Exercisable at the end of the period (in shares)	1,211,136
Options exercisable and expected to vest at the end of the period (in shares)	1,774,142
Weighted Average Exercise Price
Options outstanding at the beginning of the period (in dollars per share)	$ 29.61
Granted (in dollars per share)	$ 30.72
Exercised (in dollars per share)	$ 16.30
Forfeited (in dollars per share)	$ 38.98
Expired (in dollars per share)	$ 0.00
Options outstanding at the end of the period (in dollars per share)	$ 30.57	$ 29.61
Exercisable at the end of the period (in dollars per share)	$ 28.92
Options exercisable and expected to vest at the end of the period (in dollars per share)	$ 30.56
Weighted Average Remaining Contractual Term (Years)
Options outstanding at the end of the period	6 years 9 months 24 days
Exercisable at the end of the period	5 years 10 months 25 days
Options exercisable and expected to vest at the end of the period	6 years 9 months 8 days
Aggregate Intrinsic Value
Options outstanding at the end of the period (in dollars)	5,167,000
Exercisable at the end of the period (in dollars)	5,093,000
Options exercisable and expected to vest at the end of the period (in dollars)	5,157,000
Valuation Assumptions
Risk-free interest rate											0.40%	1.10%	1.40%										0.10%	0.10%	0.10%
Expected stock price volatility											46.80%	48.50%	47.80%										46.40%	49.00%	43.40%
Expected dividend yield											2.60%	2.20%	1.60%										2.80%	2.20%	1.60%
Expected life of stock options											3 years 7 months 6 days	3 years 8 months 16 days	3 years 8 months 16 days										3 months	3 months	3 months
Share-Based Compensation, Additional Disclosures
Weighted average fair values of nonvested stock awards/units granted during the period (in dollars per share)																	$ 29.71	$ 38.98	$ 45.51				$ 6.84	$ 9.35	$ 9.39
Weighted average fair values of stock options granted during the period (in dollars per share)	$ 8.92	$ 11.58	$ 14.36
Total intrinsic value of options exercised (in dollars)	3,400,000	5,900,000	24,900,000
Cash received from option exercises	5,100,000	7,200,000	19,900,000
Excess tax benefits from share-based compensation	1,302,000	1,992,000	8,700,000								800,000						500,000
Excess tax shortfall included in cash flows from operating activities											1,700,000						1,500,000
Income tax benefit on recognized compensation cost											1,700,000						3,900,000
Unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock options/awards/units											$ 4,900,000						$ 18,400,000
Weighted-average period for recognition of unrecognized compensation cost (in years/months)											1 year 8 months 4 days						1 year 9 months 18 days